Ocean Capital Management, LLC Amgen Inc Transaction History

Ocean Capital Management, LLC

$426 Million
Q3 2024

A detailed history of Ocean Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Ocean Capital Management, LLC holds 6,052 shares of AMGN stock, worth $1.74 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

6,052

Previous 1,215 398.11%

Holding current value

$1.74 Million

Previous $379,000 414.51%

% of portfolio

0.46%

Previous 0.13%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$309.38 - $337.38 $1.5 Million - $1.63 Million	4,837 Added 398.11%	6,052 $1.95 Million
Q1 2024 May 03, 2024	SELL	$268.87 - $324.56 $17,476 - $21,096	-65 Reduced 5.08%	1,215 $345,000
Q4 2022 Feb 02, 2023	SELL	$229.03 - $291.01 $20,612 - $26,190	-90 Reduced 6.57%	1,280 $336,000
Q2 2022 Jul 27, 2022	SELL	$230.71 - $256.74 $2,307 - $2,567	-10 Reduced 0.72%	1,370 $333,000
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $8,770 - $9,702	-40 Reduced 2.82%	1,380 $337,000
Q4 2021 Jan 31, 2022	SELL	$198.88 - $227.6 $3,977 - $4,552	-20 Reduced 1.39%	1,420 $319,000
Q2 2021 Jul 22, 2021	SELL	$233.58 - $259.14 $46,716 - $51,828	-200 Reduced 12.2%	1,440 $351,000
Q1 2021 May 06, 2021	SELL	$221.91 - $258.6 $44,382 - $51,720	-200 Reduced 10.87%	1,640 $409,000
Q3 2020 Nov 09, 2020	BUY	$234.65 - $260.95 $2,346 - $2,609	10 Added 0.55%	1,840 $466,000
Q1 2020 Apr 16, 2020	SELL	$182.24 - $241.7 $3,644 - $4,834	-20 Reduced 1.08%	1,830 $371,000
Q1 2019 May 23, 2019	SELL	$180.87 - $203.88 $19,895 - $22,426	-110 Reduced 5.61%	1,850 $351,000
Q4 2018 Jan 29, 2019	BUY	$178.4 - $208.25 $349,664 - $408,170	1,960 New	1,960 $382,000

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ocean Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ocean Capital Management, LLC with notifications on news.

Account

Ocean Capital Management, LLC Amgen Inc Transaction History